US4675189A
(en)
*
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
US5366734A
(en)
*
|
1981-02-16 |
1994-11-22 |
Zeneca Limited |
Continuous release pharmaceutical compositions
|
CH660488A5
(en)
*
|
1982-12-17 |
1987-04-30 |
Sandoz Ag |
(Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions
|
CA1196864A
(en)
*
|
1983-06-10 |
1985-11-19 |
Mattheus F.A. Goosen |
Controlled release of injectable and implantable insulin compositions
|
CH656884A5
(de)
*
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
GB8416234D0
(en)
*
|
1984-06-26 |
1984-08-01 |
Ici Plc |
Biodegradable amphipathic copolymers
|
JPS6136321A
(ja)
*
|
1984-07-27 |
1986-02-21 |
Daicel Chem Ind Ltd |
新規なポリマ−およびその樹脂組成物
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
US5411951A
(en)
*
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
US5474980A
(en)
*
|
1984-10-04 |
1995-12-12 |
Monsanto Company |
Prolonged release of biologically active somatotropins
|
KR890002631B1
(ko)
*
|
1984-10-04 |
1989-07-21 |
몬산토 캄파니 |
생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
|
JPH0611709B2
(ja)
*
|
1984-10-19 |
1994-02-16 |
チロン コーポレイション |
角膜基質創傷の治療のための組成物
|
US4895724A
(en)
*
|
1985-06-07 |
1990-01-23 |
Pfizer Inc. |
Chitosan compositions for controlled and prolonged release of macromolecules
|
US5036045A
(en)
*
|
1985-09-12 |
1991-07-30 |
The University Of Virginia Alumni Patents Foundation |
Method for increasing growth hormone secretion
|
US5102872A
(en)
*
|
1985-09-20 |
1992-04-07 |
Cetus Corporation |
Controlled-release formulations of interleukin-2
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
US4832686A
(en)
*
|
1986-06-24 |
1989-05-23 |
Anderson Mark E |
Method for administering interleukin-2
|
US4801457A
(en)
*
|
1986-08-01 |
1989-01-31 |
Sandoz Pharm. Corp. |
Polyacetal hydrogels formed from divinyl ethers and polyols
|
US4882168A
(en)
*
|
1986-09-05 |
1989-11-21 |
American Cyanamid Company |
Polyesters containing alkylene oxide blocks as drug delivery systems
|
JPH0725689B2
(ja)
*
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
US5811128A
(en)
*
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
US5075109A
(en)
*
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
US5037644A
(en)
*
|
1986-10-27 |
1991-08-06 |
Cetus Corporation |
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
|
US5183746A
(en)
*
|
1986-10-27 |
1993-02-02 |
Schering Aktiengesellschaft |
Formulation processes for pharmaceutical compositions of recombinant β-
|
US5688519A
(en)
*
|
1987-04-06 |
1997-11-18 |
Leonard; Robert J. |
Flash-flow fused medicinal implants
|
US5000886A
(en)
*
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US4992418A
(en)
*
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US5017560A
(en)
*
|
1987-11-06 |
1991-05-21 |
Pitman-Moore, Inc. |
Poultry growth promotion
|
US5004605A
(en)
*
|
1987-12-10 |
1991-04-02 |
Cetus Corporation |
Low pH pharmaceutical compositions of recombinant β-interferon
|
JPH01163135A
(ja)
*
|
1987-12-18 |
1989-06-27 |
Taki Chem Co Ltd |
徐放性基剤の製造方法
|
GB8801863D0
(en)
*
|
1988-01-28 |
1988-02-24 |
Fulmer Yarsley Ltd |
Pharmaceutical formulations with controlled drug release
|
US5137669A
(en)
*
|
1988-03-02 |
1992-08-11 |
Endocon, Inc. |
Manufacture of partially fused peptide pellet
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US5078997A
(en)
*
|
1988-07-13 |
1992-01-07 |
Cetus Corporation |
Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
|
US5216050A
(en)
*
|
1988-08-08 |
1993-06-01 |
Biopak Technology, Ltd. |
Blends of polyactic acid
|
US5252642A
(en)
*
|
1989-03-01 |
1993-10-12 |
Biopak Technology, Ltd. |
Degradable impact modified polyactic acid
|
US5444113A
(en)
*
|
1988-08-08 |
1995-08-22 |
Ecopol, Llc |
End use applications of biodegradable polymers
|
US4925677A
(en)
*
|
1988-08-31 |
1990-05-15 |
Theratech, Inc. |
Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
|
JPH064540B2
(ja)
*
|
1988-09-14 |
1994-01-19 |
多木化学株式会社 |
医用組成物
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
WO1990010437A1
(en)
*
|
1989-03-09 |
1990-09-20 |
Endocon, Inc. |
Partially fused peptide pellet
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5538739A
(en)
*
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
US5324519A
(en)
*
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US5487897A
(en)
*
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
DE59003337D1
(de)
*
|
1989-10-16 |
1993-12-09 |
Danubia Petrochem Polymere |
Pressling mit retardierter Wirkstofffreisetzung.
|
DE3935736A1
(de)
*
|
1989-10-27 |
1991-05-02 |
Chemie Linz Deutschland |
Pressling mit retardierter wirkstofffreisetzung
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
US5091185A
(en)
*
|
1990-06-20 |
1992-02-25 |
Monsanto Company |
Coated veterinary implants
|
US5360892A
(en)
*
|
1990-06-26 |
1994-11-01 |
Arch Development Corporation |
Water and UV degradable lactic acid polymers
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
IE912365A1
(en)
*
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
US6353030B1
(en)
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
US5626863A
(en)
*
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
IT1243390B
(it)
*
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
AU1979392A
(en)
*
|
1991-05-14 |
1992-12-30 |
Endocon, Inc. |
Engineering the local inflammatory response as a means of controlled release drug delivery
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
FR2678168B1
(fr)
|
1991-06-28 |
1993-09-03 |
Rhone Poulenc Rorer Sa |
Nanoparticules ayant un temps de capture par le dysteme reticulo endothelial allonge.
|
EP0596123A4
(de)
*
|
1991-10-31 |
1995-03-29 |
Kobe Steel Ltd |
Biologisch abbaubares kunststoffmaterial.
|
DE69329594T2
(de)
*
|
1992-02-28 |
2001-05-31 |
Univ Texas |
Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
US5352515A
(en)
*
|
1992-03-02 |
1994-10-04 |
American Cyanamid Company |
Coating for tissue drag reduction
|
US5518730A
(en)
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
US5981719A
(en)
*
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
*
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
KR960015447B1
(ko)
*
|
1993-03-16 |
1996-11-14 |
주식회사 삼양사 |
의료용 생분해성 고분자
|
US6284727B1
(en)
*
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
HU225496B1
(en)
*
|
1993-04-07 |
2007-01-29 |
Scios Inc |
Pharmaceutical compositions of prolonged delivery, containing peptides
|
US20050181976A1
(en)
*
|
1993-05-10 |
2005-08-18 |
Ekwuribe Nnochiri N. |
Amphiphilic oligomers
|
US5359030A
(en)
*
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
US6191105B1
(en)
*
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
US5522841A
(en)
*
|
1993-05-27 |
1996-06-04 |
United States Surgical Corporation |
Absorbable block copolymers and surgical articles fabricated therefrom
|
JP3220331B2
(ja)
*
|
1993-07-20 |
2001-10-22 |
エチコン・インコーポレーテツド |
非経口投与用の吸収性液体コポリマー類
|
US5565215A
(en)
*
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
US5543158A
(en)
*
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
US5876438A
(en)
*
|
1993-08-02 |
1999-03-02 |
Houston Biotechnology Incorporated |
Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
|
US5563238A
(en)
*
|
1993-08-05 |
1996-10-08 |
Arch Development Corporation |
Water and UV degradable lactic acid polymers
|
KR0148704B1
(ko)
*
|
1994-01-10 |
1998-08-17 |
김상응 |
생체분해성 약물전달용 고분자
|
US5569468A
(en)
*
|
1994-02-17 |
1996-10-29 |
Modi; Pankaj |
Vaccine delivery system for immunization, using biodegradable polymer microspheres
|
US5417982A
(en)
*
|
1994-02-17 |
1995-05-23 |
Modi; Pankaj |
Controlled release of drugs or hormones in biodegradable polymer microspheres
|
US5527271A
(en)
*
|
1994-03-30 |
1996-06-18 |
Bristol-Myers Squibb Co. |
Thermoplastic hydrogel impregnated composite material
|
KR0141431B1
(ko)
*
|
1994-05-17 |
1998-07-01 |
김상웅 |
생분해성 하이드로겔 고분자
|
GB9412273D0
(en)
*
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
US6007845A
(en)
*
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US6063116A
(en)
*
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
US5714573A
(en)
*
|
1995-01-19 |
1998-02-03 |
Cargill, Incorporated |
Impact modified melt-stable lactide polymer compositions and processes for manufacture thereof
|
US5618850A
(en)
|
1995-03-09 |
1997-04-08 |
Focal, Inc. |
Hydroxy-acid cosmetics
|
US5939157A
(en)
*
|
1995-10-30 |
1999-08-17 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
US5985383A
(en)
*
|
1995-03-15 |
1999-11-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
US5955159A
(en)
*
|
1995-03-15 |
1999-09-21 |
Acushnet Company |
Conforming shoe construction using gels and method of making the same
|
JP3145409B2
(ja)
|
1995-03-24 |
2001-03-12 |
フォーカル, インコーポレイテッド |
活性酸素阻害剤の制御送達を用いる癒着の低減
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US5904935A
(en)
*
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
DE69636006T2
(de)
*
|
1995-06-12 |
2006-11-23 |
MicroActive Corp., Reno |
Transparente biozide zusammensetzungen mit verzögerter freigabe
|
CA2228118A1
(en)
|
1995-07-28 |
1997-02-13 |
Focal, Inc. |
Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatments agents
|
KR0180334B1
(ko)
*
|
1995-09-21 |
1999-03-20 |
김윤 |
블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US5766704A
(en)
*
|
1995-10-27 |
1998-06-16 |
Acushnet Company |
Conforming shoe construction and gel compositions therefor
|
FR2741628B1
(fr)
*
|
1995-11-29 |
1998-02-06 |
Centre Nat Rech Scient |
Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
ATE302599T1
(de)
*
|
1996-05-24 |
2005-09-15 |
Angiotech Pharm Inc |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
TW555765B
(en)
|
1996-07-09 |
2003-10-01 |
Amgen Inc |
Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
|
US5756651A
(en)
*
|
1996-07-17 |
1998-05-26 |
Chronopol, Inc. |
Impact modified polylactide
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
ZA978537B
(en)
*
|
1996-09-23 |
1998-05-12 |
Focal Inc |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
|
US6191236B1
(en)
|
1996-10-11 |
2001-02-20 |
United States Surgical Corporation |
Bioabsorbable suture and method of its manufacture
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6197350B1
(en)
*
|
1996-12-20 |
2001-03-06 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
CA2274676A1
(en)
|
1996-12-31 |
1998-07-09 |
James Hongxue Wang |
Water-responsive polymer compositions and method of making the same
|
US6402520B1
(en)
*
|
1997-04-30 |
2002-06-11 |
Unique Logic And Technology, Inc. |
Electroencephalograph based biofeedback system for improving learning skills
|
EP0986402A2
(de)
|
1997-06-06 |
2000-03-22 |
Battelle Memorial Institute |
Reversibles gelbindendes copolymer und verfahren
|
US5945480A
(en)
*
|
1997-07-31 |
1999-08-31 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable fibers comprising polylactide modified polylactide and polyvinyl alcohol, and method for making the fibers
|
US5952433A
(en)
*
|
1997-07-31 |
1999-09-14 |
Kimberly-Clark Worldwide, Inc. |
Modified polyactide compositions and a reactive-extrusion process to make the same
|
US6075118A
(en)
*
|
1997-07-31 |
2000-06-13 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable film compositions comprising polylactide and polyvinyl alcohol, and a method for making the films
|
US6552162B1
(en)
|
1997-07-31 |
2003-04-22 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable compositions and films and articles comprising a blend of polylactide and polyvinyl alcohol and methods for making the same
|
CA2299393A1
(en)
*
|
1997-08-08 |
1999-02-18 |
Sung Wan Kim |
Injectable biodegradable block copolymer gels for use in drug delivery
|
US5852117A
(en)
*
|
1997-08-26 |
1998-12-22 |
National Starch And Chemical Investment Holding Corporation |
Process for making lactide graft copolymers
|
US6007565A
(en)
*
|
1997-09-05 |
1999-12-28 |
United States Surgical |
Absorbable block copolymers and surgical articles fabricated therefrom
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US20020164374A1
(en)
*
|
1997-10-29 |
2002-11-07 |
John Jackson |
Polymeric systems for drug delivery and uses thereof
|
US6277927B1
(en)
|
1997-11-26 |
2001-08-21 |
United States Surgical Corporation |
Absorbable block copolymers and surgical articles fabricated therefrom
|
US6613358B2
(en)
|
1998-03-18 |
2003-09-02 |
Theodore W. Randolph |
Sustained-release composition including amorphous polymer
|
WO1999047543A2
(en)
*
|
1998-03-18 |
1999-09-23 |
University Technology Corporation |
Sustained-release composition including amorphous polymer
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
ME00867B
(me)
*
|
1998-03-19 |
2008-08-07 |
Merck Sharp & Dohme |
Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci
|
DE19812688A1
(de)
*
|
1998-03-23 |
1999-09-30 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
US6841617B2
(en)
*
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
US7087244B2
(en)
*
|
2000-09-28 |
2006-08-08 |
Battelle Memorial Institute |
Thermogelling oligopeptide polymers
|
US20040228794A1
(en)
*
|
1998-04-10 |
2004-11-18 |
Battelle Memorial Institute |
Therapeutic agent carrier compositions
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
US6350518B1
(en)
|
1998-06-01 |
2002-02-26 |
Kimberly-Clark Worldwide, Inc. |
Methods of making blend compositions of an unmodified poly vinyl alcohol and a thermoplastic elastomer
|
DE69920711D1
(de)
*
|
1998-07-21 |
2004-11-04 |
Monsanto Technology Llc |
Klärung von protein-niederschlagsuspensionen durch verwendung von anionischen polymerischen flockungsmitteln
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
US6451346B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Amgen Inc |
Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
|
ES2220406T3
(es)
*
|
1999-02-19 |
2004-12-16 |
Universiteit Utrecht |
Hidrogeles estereocomplejos.
|
JP4548623B2
(ja)
*
|
1999-02-24 |
2010-09-22 |
多木化学株式会社 |
生体材料
|
WO2000054797A2
(en)
|
1999-03-17 |
2000-09-21 |
Novartis Ag |
Pharmaceutical compositions comprising tgf-beta
|
US6217630B1
(en)
|
1999-05-03 |
2001-04-17 |
Cargill, Incorporated |
Conditioned fertilizer product, method for conditioning fertilizer, and method for using conditioned fertilizer product
|
WO2000071602A1
(fr)
*
|
1999-05-19 |
2000-11-30 |
Nof Corporation |
Polymere, materiau degradable in vivo et utilisation
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US6521431B1
(en)
*
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US7279176B1
(en)
|
1999-09-02 |
2007-10-09 |
Rice University |
Nitric oxide-producing hydrogel materials
|
US7052711B2
(en)
*
|
1999-09-02 |
2006-05-30 |
Rice University |
Nitric oxide-producing hydrogel materials
|
US8226598B2
(en)
*
|
1999-09-24 |
2012-07-24 |
Tolmar Therapeutics, Inc. |
Coupling syringe system and methods for obtaining a mixed composition
|
US6656467B2
(en)
*
|
2000-01-27 |
2003-12-02 |
Medimmune, Inc. |
Ultra high affinity neutralizing antibodies
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
DK1259547T3
(da)
*
|
2000-03-01 |
2012-10-15 |
Medimmune Inc |
Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
|
EP1263491A2
(de)
*
|
2000-03-01 |
2002-12-11 |
Glaxo Group Limited |
Dosierbarer inhalator
|
US7193007B2
(en)
*
|
2000-03-15 |
2007-03-20 |
Yu-Ling Cheng |
Environment responsive gelling copolymer
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
US20040023987A1
(en)
*
|
2000-06-14 |
2004-02-05 |
Yoshio Hata |
Sustained release compositions
|
AU2001281921A1
(en)
*
|
2000-06-29 |
2002-01-08 |
Bernina Biosystems Gmbh |
Bdellosomes
|
US6338859B1
(en)
*
|
2000-06-29 |
2002-01-15 |
Labopharm Inc. |
Polymeric micelle compositions
|
KR100451910B1
(ko)
*
|
2000-10-05 |
2004-10-08 |
주식회사 바이오폴리테크 |
수용성 생체분해성 고분자 겔 및 그의 제조방법
|
DE10055742B4
(de)
*
|
2000-11-10 |
2006-05-11 |
Schwarz Pharma Ag |
Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen
|
JP4434580B2
(ja)
|
2000-11-28 |
2010-03-17 |
メディミューン,エルエルシー |
予防及び治療のために抗rsv抗体を投与/処方する方法
|
US7179900B2
(en)
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6855493B2
(en)
*
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
ES2649037T3
(es)
|
2000-12-12 |
2018-01-09 |
Medimmune, Llc |
Moléculas con semividas prolongadas, composiciones y usos de las mismas
|
AU2002231736A1
(en)
|
2000-12-22 |
2002-07-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
DE60117857D1
(de)
|
2000-12-27 |
2006-05-04 |
Genzyme Corp |
Kontrollierte freisetzung von anti-arrhythmica aus einem biodegradierbaren hydrogel für die lokale anwendung am herzen
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
WO2002098370A2
(en)
*
|
2001-03-02 |
2002-12-12 |
Medimmune, Inc. |
Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
|
DE10111767B4
(de)
*
|
2001-03-12 |
2005-03-24 |
Schwarz Pharma Ag |
Verfahren zur Herstellung von Polyestern aus Hydroxycarbonsäuren und Polyolen durch Polykondensation
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20030054036A1
(en)
*
|
2001-03-13 |
2003-03-20 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20040185101A1
(en)
*
|
2001-03-27 |
2004-09-23 |
Macromed, Incorporated. |
Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
|
DE60220519T2
(de)
*
|
2001-04-20 |
2007-09-27 |
The University Of British Columbia, Vancouver |
Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
|
US6835802B2
(en)
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6939564B2
(en)
*
|
2001-06-08 |
2005-09-06 |
Labopharm, Inc. |
Water-soluble stabilized self-assembled polyelectrolytes
|
WO2003000156A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
KR20040017297A
(ko)
*
|
2001-07-13 |
2004-02-26 |
메비올 가부시키가이샤 |
조직·장기 재생용 재료 및 조직·장기 재생 방법
|
US7309498B2
(en)
*
|
2001-10-10 |
2007-12-18 |
Belenkaya Bronislava G |
Biodegradable absorbents and methods of preparation
|
AU2002343681B2
(en)
*
|
2001-11-12 |
2006-07-06 |
Alkermes Controlled Therapeutics, Inc. |
Biocompatible polymer blends and uses thereof
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
US8323693B2
(en)
|
2002-03-14 |
2012-12-04 |
Medrx Co., Ltd. |
External preparation for wounds
|
US7018655B2
(en)
*
|
2002-03-18 |
2006-03-28 |
Labopharm, Inc. |
Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
|
CA2483778A1
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
US7649023B2
(en)
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
US7425618B2
(en)
*
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
CA2494485A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Medimmune, Inc. |
Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
|
CA2495251C
(en)
|
2002-08-14 |
2018-03-06 |
Macrogenics, Inc. |
Fc.gamma.riib-specific antibodies and methods of use thereof
|
JP4596916B2
(ja)
*
|
2002-09-05 |
2010-12-15 |
メディミューン,エルエルシー |
Cd2拮抗薬を投与することによりt細胞悪性腫瘍を予防または治療する方法
|
KR101476067B1
(ko)
*
|
2002-09-06 |
2014-12-23 |
인설트 테라페틱스, 인코퍼레이티드 |
공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
|
EP1559440B1
(de)
*
|
2002-10-29 |
2015-09-23 |
Toray Industries, Inc. |
Gefässembolisationsmaterial
|
US7407672B2
(en)
*
|
2002-11-04 |
2008-08-05 |
National Heart Center |
Composition derived from biological materials and method of use and preparation
|
AU2003285200A1
(en)
*
|
2002-11-09 |
2004-06-03 |
Nobex Corporation |
Modified carbamate-containing prodrugs and methods of synthesizing same
|
US7648962B2
(en)
*
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
EP1569683B1
(de)
|
2002-11-26 |
2010-03-03 |
Biocon Limited |
Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen
|
JP2006524039A
(ja)
|
2003-01-09 |
2006-10-26 |
マクロジェニクス,インコーポレーテッド |
変異型Fc領域を含む抗体の同定および作製ならびにその利用法
|
EP1596804A4
(de)
|
2003-01-13 |
2008-02-06 |
Macrogenics Inc |
LÖSLICHE FcyR-FUSIONSPROTEINE UND VERFAHREN ZU IHRER ANWENDUNG
|
US20040208869A1
(en)
*
|
2003-01-30 |
2004-10-21 |
Medimmune, Inc. |
Uses of anti-integrin alphanubeta3 antibody formulations
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
KR20120035234A
(ko)
|
2003-04-11 |
2012-04-13 |
메디뮨 엘엘씨 |
재조합 il?9 항체 및 그의 용도
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US20050013870A1
(en)
*
|
2003-07-17 |
2005-01-20 |
Toby Freyman |
Decellularized extracellular matrix of conditioned body tissues and uses thereof
|
US7326571B2
(en)
*
|
2003-07-17 |
2008-02-05 |
Boston Scientific Scimed, Inc. |
Decellularized bone marrow extracellular matrix
|
US20060228350A1
(en)
*
|
2003-08-18 |
2006-10-12 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
WO2005042743A2
(en)
|
2003-08-18 |
2005-05-12 |
Medimmune, Inc. |
Humanization of antibodies
|
US8153591B2
(en)
|
2003-08-26 |
2012-04-10 |
Gel-Del Technologies, Inc. |
Protein biomaterials and biocoacervates and methods of making and using thereof
|
ITMI20031872A1
(it)
*
|
2003-09-30 |
2005-04-01 |
Mediolanum Farmaceutici Srl |
Copolimeri di poliesteri e polivinilpirrolidone.
|
EP2267062B1
(de)
*
|
2003-11-04 |
2017-10-25 |
SupraPolix B.V. |
Supramolekulare polymere mit vier wasserstoffbrückenbindungen bildenden einheiten in der polymerhauptkette
|
US20060053516A1
(en)
*
|
2003-12-05 |
2006-03-09 |
The University Of Hong Kong |
Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
|
AU2004296851A1
(en)
*
|
2003-12-08 |
2005-06-23 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
JP2007517042A
(ja)
*
|
2003-12-30 |
2007-06-28 |
デュレクト コーポレーション |
活性物質、好ましくはgnrhの制御放出のための、好ましくはpegおよびplgの混合物を含有するポリマーインプラント
|
KR20050077916A
(ko)
|
2004-01-29 |
2005-08-04 |
학교법인 성균관대학 |
pH 및 온도 민감성 하이드로겔
|
CN1950429B
(zh)
*
|
2004-05-05 |
2011-08-10 |
弗门尼舍有限公司 |
生物可降解接枝共聚物
|
US20050281866A1
(en)
*
|
2004-05-24 |
2005-12-22 |
Genzyme Corporation |
Adherent polymeric compositions
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
US20050271727A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Callisyn Pharmaceuticals, Inc. |
Biodegradable and biocompatible crosslinked polymer hydrogel prepared from PVA and/or PEG macromer mixtures
|
US20060004185A1
(en)
*
|
2004-07-01 |
2006-01-05 |
Leese Richard A |
Peptide antibiotics and peptide intermediates for their prepartion
|
EP1773903B1
(de)
*
|
2004-07-12 |
2017-08-09 |
SupraPolix B.V. |
Supramolekulare ionomere
|
WO2006012394A1
(en)
|
2004-07-21 |
2006-02-02 |
Tulane University Health Sciences Center |
Treatment of renal dysfunction and multiple myeloma using pacap compounds
|
US8357391B2
(en)
*
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
US20060034889A1
(en)
|
2004-08-16 |
2006-02-16 |
Macromed, Inc. |
Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
|
AU2005299355A1
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune, Llc |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
AU2005302453A1
(en)
*
|
2004-10-29 |
2006-05-11 |
Medimmune, Llc |
Methods of preventing and treating RSV infections and related conditions
|
US20060149363A1
(en)
*
|
2005-01-06 |
2006-07-06 |
Scimed Life Systems, Inc. |
Optimally expanded, collagen sealed ePTFE graft with improved tissue ingrowth
|
US8128952B2
(en)
*
|
2005-01-12 |
2012-03-06 |
Clemson University Research Foundation |
Ligand-mediated controlled drug delivery
|
WO2006076471A2
(en)
*
|
2005-01-12 |
2006-07-20 |
Nobex Corporation |
Bnp conjugates and methods of use
|
JP5153613B2
(ja)
|
2005-03-18 |
2013-02-27 |
メディミューン,エルエルシー |
抗体のフレームワーク・シャッフル
|
KR100665672B1
(ko)
*
|
2005-04-13 |
2007-01-09 |
성균관대학교산학협력단 |
새로운 온도 및 pH 민감성 블록 공중합체 및 이를 이용한고분자 하이드로겔
|
CA2605024C
(en)
|
2005-04-15 |
2018-05-22 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
ES2367583T3
(es)
*
|
2005-05-04 |
2011-11-10 |
Suprapolix B.V. |
Hidrogeles con enlaces de hidrógeno.
|
EP1877113B1
(de)
|
2005-05-04 |
2011-11-09 |
SupraPolix B.V. |
Modulare bioresorbierbare oder biomedizinische biologisch aktive supramolekulare stoffe
|
CA2613512A1
(en)
|
2005-06-23 |
2007-01-04 |
Medimmune, Inc. |
Antibody formulations having optimized aggregation and fragmentation profiles
|
CN103172737A
(zh)
*
|
2005-06-30 |
2013-06-26 |
Abbvie公司 |
Il-12/p40结合蛋白
|
DK1919503T3
(en)
|
2005-08-10 |
2014-12-15 |
Macrogenics Inc |
Identification and preparation of antibodies with variant fc regions and methods of use thereof
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
AU2006283532B2
(en)
|
2005-08-19 |
2012-04-26 |
Abbvie Inc. |
Dual variable domain immunoglobin and uses thereof
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US20090215992A1
(en)
*
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
EP2500353A3
(de)
|
2005-08-19 |
2012-10-10 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
WO2007039256A2
(de)
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
|
US20070078479A1
(en)
*
|
2005-10-04 |
2007-04-05 |
Boston Scientific Scimed, Inc. |
Self-expanding vaso-occlusive devices with regulated expansion
|
US20070078480A1
(en)
*
|
2005-10-04 |
2007-04-05 |
Boston Scientific Scimed, Inc. |
Self-expanding biodegradable or water-soluble vaso-occlusive devices
|
JP5398112B2
(ja)
*
|
2005-10-27 |
2014-01-29 |
東レ株式会社 |
生分解性粒子およびその製造方法
|
US8882747B2
(en)
*
|
2005-11-09 |
2014-11-11 |
The Invention Science Fund I, Llc |
Substance delivery system
|
WO2007061896A1
(en)
|
2005-11-17 |
2007-05-31 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
BRPI0619249A2
(pt)
|
2005-11-30 |
2011-09-20 |
Abbott Lab |
anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
KR100738083B1
(ko)
*
|
2005-12-20 |
2007-07-12 |
삼성전자주식회사 |
마이크로어레이용 기판 및 그의 제조방법
|
US8916206B2
(en)
|
2005-12-26 |
2014-12-23 |
Ltt Bio-Pharma Co., Ltd. |
Nanoparticles containing water-soluble non-peptide low-molecular weight drug
|
US20070178137A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Toby Freyman |
Local control of inflammation
|
US20070239194A1
(en)
*
|
2006-04-05 |
2007-10-11 |
Boston Scientific Scimed, Inc. |
Vaso-occlusive devices having expandable fibers
|
US20070280986A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Carlos Gil |
Intra-operative coating of implants
|
EP2037961B1
(de)
|
2006-06-14 |
2015-11-11 |
MacroGenics, Inc. |
Verfahren zur behandlung von autoimmunerkrankungen anhand von monoklonalen antikörpern mit verminderter toxizität
|
EP2029173B1
(de)
|
2006-06-26 |
2016-07-20 |
MacroGenics, Inc. |
Fc-riib-spezifische antikörper und verfahren zu ihrer anwendung
|
MY162024A
(en)
|
2006-08-28 |
2017-05-31 |
La Jolla Inst Allergy & Immunology |
Antagonistic human light-specific human monoclonal antibodies
|
UA115964C2
(uk)
|
2006-09-08 |
2018-01-25 |
Еббві Айрленд Анлімітед Компані |
Інтерлейкін-13-зв'язувальний білок
|
JP2010504318A
(ja)
*
|
2006-09-22 |
2010-02-12 |
ラボファーム インコーポレイテッド |
pH標的化薬剤送達のための組成物及び方法
|
AU2007313300A1
(en)
|
2006-10-16 |
2008-04-24 |
Medimmune, Llc. |
Molecules with reduced half-lives, compositions and uses thereof
|
US20080138397A1
(en)
*
|
2006-10-24 |
2008-06-12 |
Aradigm Corporation |
Processes for taste-masking of inhaled formulations
|
DE602007008125D1
(de)
*
|
2006-10-31 |
2010-09-09 |
Surmodics Pharmaceuticals Inc |
Kugelförmige polymer-teilchen
|
ATE527305T1
(de)
|
2006-11-20 |
2011-10-15 |
Suprapolix Bv |
Supramolekulare polymere aus niedrigschmelzenden, leicht verarbeitbaren bausteinen
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
ATE515538T1
(de)
|
2007-03-23 |
2011-07-15 |
Suprapolix Bv |
Starke umkehrbare hydrogels
|
US8628789B2
(en)
|
2007-03-23 |
2014-01-14 |
Suprapolix, B.V. |
Strong reversible hydrogels
|
KR100838809B1
(ko)
*
|
2007-05-03 |
2008-06-17 |
성균관대학교산학협력단 |
겔강도가 우수한 온도 및 피에치 민감성 블록 공중합체 및이의 제조방법과 이를 이용한 약물전달체
|
US20100129456A1
(en)
|
2007-05-14 |
2010-05-27 |
Ltt Bio-Pharma Co., Ltd. |
Sustained-release nanoparticle containing low-molecular-weight drug with negatively charged group
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
EP1997830A1
(de)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
|
JP5718637B2
(ja)
|
2007-06-21 |
2015-05-13 |
マクロジェニクス,インコーポレーテッド |
共有結合型ダイアボディおよびその使用
|
US20090155275A1
(en)
|
2007-07-31 |
2009-06-18 |
Medimmune, Llc |
Multispecific epitope binding proteins and uses thereof
|
KR100941774B1
(ko)
*
|
2007-09-06 |
2010-02-11 |
성균관대학교산학협력단 |
인체안전성이 우수한 온도 및 피에치 민감성 블록공중합체및 이의 제조방법과 이를 이용한 약물전달체
|
WO2009086483A2
(en)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
US20110033378A1
(en)
|
2008-01-18 |
2011-02-10 |
Medlmmune, Llc. |
Cysteine Engineered Antibodies For Site-Specific Conjugation
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
EP2756756B1
(de)
|
2008-04-28 |
2016-01-06 |
Zogenix, Inc. |
Neuartige Formulierungen zur Behandlung von Migräne
|
CA2722466A1
(en)
|
2008-04-29 |
2009-11-05 |
Tariq Ghayur |
Dual variable domain immunoglobulins and uses thereof
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
KR101649189B1
(ko)
|
2008-05-09 |
2016-08-18 |
애브비 인코포레이티드 |
최종 당화 산물의 수용체(rage)에 대한 항체 및 이의 용도
|
AU2009256250B2
(en)
|
2008-06-03 |
2013-05-30 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
CA2725666A1
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
WO2010002262A1
(en)
*
|
2008-07-04 |
2010-01-07 |
Suprapolix B.V. |
High flow supramolecular compounds
|
RU2559525C2
(ru)
|
2008-07-08 |
2015-08-10 |
Эббви Инк |
Белки, связывающие простагландин е2, и их применение
|
NZ590074A
(en)
*
|
2008-07-08 |
2012-12-21 |
Abbott Lab |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
AU2009270695A1
(en)
|
2008-07-17 |
2010-01-21 |
Ap Pharma |
Methods for enhancing the stability of polyorthoesters and their formulations
|
KR100987693B1
(ko)
*
|
2008-10-20 |
2010-10-13 |
서울대학교산학협력단 |
폴리(에틸렌 글리콜)-b-[폴리(L-세린)-g-폴리(D,L-락티드)]의 블록공중합체 및 이를 이용한 약물전달체용 나노입자의 제조 방법
|
WO2010057177A2
(en)
|
2008-11-17 |
2010-05-20 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US20100233079A1
(en)
*
|
2008-12-04 |
2010-09-16 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
CN106432503B
(zh)
|
2008-12-19 |
2020-03-06 |
宏观基因有限公司 |
共价双抗体及其用途
|
AR074874A1
(es)
|
2008-12-23 |
2011-02-16 |
Biosource Pharm Inc |
Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
|
TW201031421A
(en)
*
|
2009-01-29 |
2010-09-01 |
Abbott Lab |
IL-1 binding proteins
|
US20110165063A1
(en)
*
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
NZ594514A
(en)
*
|
2009-03-05 |
2013-06-28 |
Abbott Lab |
Interleukin-17 BINDING PROTEINS
|
US8283162B2
(en)
|
2009-03-10 |
2012-10-09 |
Abbott Laboratories |
Antibodies relating to PIVKAII and uses thereof
|
EP2437767B1
(de)
|
2009-06-01 |
2015-07-08 |
MedImmune, LLC |
Moleküle mit verlängerter halbwertzeit und verwendungen dafür
|
US20120213705A1
(en)
|
2009-06-22 |
2012-08-23 |
Medimmune, Llc |
ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
|
TWI465250B
(zh)
|
2009-08-29 |
2014-12-21 |
Abbvie Inc |
治療用之dll4結合蛋白質
|
IN2012DN02737A
(de)
*
|
2009-09-01 |
2015-09-11 |
Abbott Lab |
|
MX366955B
(es)
|
2009-09-15 |
2019-07-31 |
Bluelink Pharmaceuticals Inc |
Crlx101 para usarse en el tratamiento de cáncer.
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
WO2011044368A1
(en)
|
2009-10-07 |
2011-04-14 |
Macrogenics, Inc. |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
|
KR20140015139A
(ko)
|
2009-10-15 |
2014-02-06 |
애브비 인코포레이티드 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US8420083B2
(en)
*
|
2009-10-31 |
2013-04-16 |
Abbvie Inc. |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
EP2496245B1
(de)
|
2009-11-02 |
2016-07-20 |
The Administrators Of The Tulane |
Analoge des pitutären adenylatcyclase-aktivierenden polypeptids (pacap) und verfahren zu ihrer verwendung
|
NZ599527A
(en)
|
2009-11-09 |
2014-04-30 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
CN102695500A
(zh)
|
2009-11-09 |
2012-09-26 |
聚光灯技术合伙有限责任公司 |
多糖基水凝胶
|
EP2503888A4
(de)
*
|
2009-11-23 |
2015-07-29 |
Cerulean Pharma Inc |
Polymere auf cyclodextrinbasis zur therapeutischen verabreichung
|
CN102656190A
(zh)
*
|
2009-12-08 |
2012-09-05 |
雅培股份有限两合公司 |
用于在视网膜神经纤维层变性治疗中使用的针对rgm a蛋白质的单克隆抗体
|
EP2542582A4
(de)
|
2010-03-02 |
2013-12-04 |
Abbvie Inc |
Therapeutische dll4-bindende proteine
|
MX360403B
(es)
|
2010-04-15 |
2018-10-31 |
Abbvie Inc |
Proteinas de union a amiloide beta.
|
BR112012028326A2
(pt)
|
2010-05-06 |
2017-03-21 |
Novartis Ag |
anticorpo multivalente isolado, anticorpos biparatópicos isolados, ácido nucleico, vetor, composição farmacêutica, método de obtenção dos referidos anticorpos, bem como uso do dos mesmos
|
EP4234698A3
(de)
|
2010-05-06 |
2023-11-08 |
Novartis AG |
Zusammensetzungen und verfahren zur verwendung von therapeutischen antikörpern gegen ldl-assoziiertes protein 6 (lrp6)
|
EP2571532B1
(de)
|
2010-05-14 |
2017-05-03 |
Abbvie Inc. |
Il-1-bindende proteine
|
AU2011255647A1
(en)
|
2010-05-18 |
2012-11-15 |
Cerulean Pharma Inc. |
Compositions and methods for treatment of autoimmune and other diseases
|
US8415307B1
(en)
|
2010-06-23 |
2013-04-09 |
Biosource Pharm, Inc. |
Antibiotic compositions for the treatment of gram negative infections
|
WO2012006500A2
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
JP5964300B2
(ja)
|
2010-08-02 |
2016-08-03 |
マクロジェニクス,インコーポレーテッド |
共有結合型ダイアボディおよびその使用
|
CA2807014A1
(en)
|
2010-08-03 |
2012-02-09 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
JP6147665B2
(ja)
|
2010-08-14 |
2017-06-14 |
アッヴィ・インコーポレイテッド |
アミロイドベータ結合タンパク質
|
RS63063B1
(sr)
|
2010-08-19 |
2022-04-29 |
Zoetis Belgium S A |
Anti-ngf antitela i njihova upotreba
|
EA036314B1
(ru)
|
2010-08-20 |
2020-10-26 |
Новартис Аг |
Выделенные антитела к рецептору эпидермального фактора роста-3 (her3) и их фрагменты, фармацевтическая композиция, содержащая эти антитела и фрагменты, и их применение для лечения рака
|
TW201211252A
(en)
|
2010-08-26 |
2012-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
JP5999567B2
(ja)
|
2010-10-20 |
2016-09-28 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
ペンダント型親水性物質を有する生分解性組成物および関連デバイス
|
EP2450394B1
(de)
|
2010-11-05 |
2017-06-07 |
SupraPolix B.V. |
Verfahren zur Herstellung eines supramolekularen Polymers
|
US20130245233A1
(en)
|
2010-11-24 |
2013-09-19 |
Ming Lei |
Multispecific Molecules
|
CN103249436B
(zh)
|
2010-12-09 |
2015-09-30 |
东丽株式会社 |
生物降解性颗粒、血管栓塞材料及生物降解性颗粒的制造方法
|
EP2656864B1
(de)
|
2010-12-20 |
2016-09-21 |
Toray Industries, Inc. |
Biologisch abbaubare partikel zur medizinischen behandlung und gefässembolisierungsmaterial
|
TW201307388A
(zh)
|
2010-12-21 |
2013-02-16 |
Abbott Lab |
Il-1結合蛋白
|
RU2627171C2
(ru)
|
2010-12-21 |
2017-08-03 |
Эббви Инк. |
Il-1 альфа и бета биспецифические иммуноглобулины с двойными вариабельными доменами и их применение
|
PT2658525T
(pt)
|
2010-12-29 |
2017-11-30 |
Medincell |
Composições biodegradáveis de entrega de fármaco
|
CN103442742B
(zh)
|
2011-03-30 |
2016-08-10 |
东丽株式会社 |
生物降解性粒子、血管栓塞材料及生物降解性粒子的制造方法
|
CA2833636A1
(en)
|
2011-04-20 |
2012-10-26 |
Amplimmune, Inc. |
Antibodies and other molecules that bind b7-h1 and pd-1
|
JP6145088B2
(ja)
|
2011-05-21 |
2017-06-07 |
マクロジェニクス,インコーポレーテッド |
脱免疫化血清結合ドメイン及び血清半減期を延長するためのその使用
|
CN103608424B
(zh)
|
2011-06-30 |
2015-11-25 |
圣戈班磨料磨具有限公司 |
涂覆的磨料聚集体和包含其的产品
|
SG10201505454SA
(en)
|
2011-07-13 |
2015-09-29 |
Abbvie Inc |
Methods and compositions for treating asthma using anti-il-13 antibodies
|
AU2012296613B2
(en)
|
2011-08-15 |
2016-05-12 |
Amplimmune, Inc. |
Anti-B7-H4 antibodies and their uses
|
SG10201504605RA
(en)
|
2011-09-23 |
2015-07-30 |
Technophage Investigação E Desenvolvimento Em Biotecnologia Sa |
Anti-Tumor Necrosis Factor-Alpha Agents And Uses Thereof
|
RU2014120981A
(ru)
|
2011-10-24 |
2015-12-10 |
Эббви Инк. |
Иммунные связывающие агенты против склеростина
|
WO2013084148A2
(en)
|
2011-12-05 |
2013-06-13 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (her3) directed to domain ii of her3
|
EA036739B1
(ru)
|
2011-12-05 |
2020-12-15 |
Новартис Аг |
Антитела к рецептору эпидермального фактора роста 3 (her3)
|
US9636398B2
(en)
|
2011-12-14 |
2017-05-02 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2791173B1
(de)
|
2011-12-14 |
2020-07-29 |
AbbVie Deutschland GmbH & Co. KG |
Zusammensetzung und verfahren zur diagnose und behandlung von durch eisenmangel bedingten erkrankungen
|
CA2859755C
(en)
|
2011-12-23 |
2021-04-20 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
UY34558A
(es)
|
2011-12-30 |
2013-07-31 |
Abbvie Inc |
Proteínas de unión específicas duales dirigidas contra il-13 y/o il-17
|
IL305223A
(en)
|
2012-01-27 |
2023-10-01 |
Abbvie Inc |
The composition and method for the diagnosis and treatment of diseases related to the degeneration of nerve cells
|
KR20130090950A
(ko)
|
2012-02-07 |
2013-08-16 |
성균관대학교산학협력단 |
듀얼 전이 고분자 하이드로젤 및 이의 이용
|
US10179173B2
(en)
*
|
2012-03-23 |
2019-01-15 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
CA2866281C
(en)
|
2012-03-28 |
2016-11-01 |
Toray Industries, Inc. |
Biodegradable material and method for producing biodegradable material
|
US9504768B2
(en)
|
2012-03-28 |
2016-11-29 |
Toray Industries, Inc. |
Biodegradable material and method of producing biodegradable material
|
JP6321633B2
(ja)
|
2012-06-04 |
2018-05-09 |
ノバルティス アーゲー |
部位特異的標識法およびそれによって生成される分子
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
AU2013337775B2
(en)
|
2012-11-01 |
2017-03-30 |
Abbvie Inc. |
Anti-VEGF/DLL4 dual variable domain immunoglobulins and uses thereof
|
RU2015115956A
(ru)
|
2012-11-09 |
2017-01-10 |
Пфайзер Инк. |
Антитела, специфичные в отношении фактора роста тромбоцитов в, и их композиции и применения
|
WO2014100483A1
(en)
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
Anti-human b7-h4 antibodies and their uses
|
CA2896091C
(en)
|
2012-12-21 |
2018-06-19 |
Amplimmune, Inc. |
Anti-h7cr antibodies
|
WO2014124258A2
(en)
|
2013-02-08 |
2014-08-14 |
Irm Llc |
Specific sites for modifying antibodies to make immunoconjugates
|
PT2953976T
(pt)
|
2013-02-08 |
2021-06-23 |
Novartis Ag |
Sítios específicos de modificação de anticorpos para preparar imunoconjugados
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
EP3916103A1
(de)
|
2013-03-14 |
2021-12-01 |
Abbott Laboratories |
Monoklonale antikörper gegen hcv-core lipid-bindender domäne
|
BR112015023355A8
(pt)
|
2013-03-14 |
2018-01-30 |
Abbott Lab |
antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
|
CN105246916A
(zh)
|
2013-03-14 |
2016-01-13 |
诺华股份有限公司 |
针对notch 3的抗体
|
CA2906421C
(en)
|
2013-03-14 |
2022-08-16 |
George J. Dawson |
Hcv antigen-antibody combination assay and methods and compositions for use therein
|
CN105324396A
(zh)
|
2013-03-15 |
2016-02-10 |
艾伯维公司 |
针对IL-1β和/或IL-17的双重特异性结合蛋白
|
MA38396B1
(fr)
|
2013-03-15 |
2019-05-31 |
Novartis Ag |
Anticorps medicamenteux conjugues et leurs compositions pharmaceutiques pour traiter un cancer positif a ckit
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
JP6682426B2
(ja)
|
2013-05-24 |
2020-04-15 |
メディミューン,エルエルシー |
抗b7−h5抗体およびその使用
|
EP3003390B1
(de)
|
2013-06-06 |
2021-07-07 |
Pierre Fabre Médicament |
Anti-c10orf54-antikörper und verwendungen davon
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
UA116479C2
(uk)
|
2013-08-09 |
2018-03-26 |
Макродженікс, Інк. |
БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
|
US11384149B2
(en)
|
2013-08-09 |
2022-07-12 |
Macrogenics, Inc. |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
|
EP2840091A1
(de)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bispezifische Diabodies, die gpA33 und CD3 binden können und Anwendungen dieser
|
EP2839842A1
(de)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bispezifische monovalente Diabodies mit Fähigkeit zur Bindung von CD123 und CD3 und Verwendungen davon
|
WO2015058868A1
(en)
|
2013-10-25 |
2015-04-30 |
Pangaea Biotech, S.L. |
Compositions and methods for the treatment of cancer
|
GB201318990D0
(en)
|
2013-10-28 |
2013-12-11 |
Omg Plc |
Optical sighting
|
CA3056647A1
(en)
|
2013-11-13 |
2015-05-21 |
Robert ARCH |
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
|
WO2015084883A2
(en)
|
2013-12-02 |
2015-06-11 |
Abbvie, Inc. |
Compositions and methods for treating osteoarthritis
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
LT3097122T
(lt)
|
2014-01-24 |
2020-07-27 |
Ngm Biopharmaceuticals, Inc. |
Antikūnai, surišantys beta kloto domeną 2, ir jų panaudojimo būdai
|
CN106604740A
(zh)
|
2014-02-14 |
2017-04-26 |
宏观基因有限公司 |
用于治疗血管化癌症的改进的方法
|
US10272117B2
(en)
|
2014-02-24 |
2019-04-30 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
WO2015138337A1
(en)
|
2014-03-09 |
2015-09-17 |
Abbvie, Inc. |
Compositions and methods for treating rheumatoid arthritis
|
MX2016011627A
(es)
|
2014-03-12 |
2016-11-29 |
Novartis Ag |
Sitios especificos para modificar anticuerpos con el fin de hacer inmunoconjugados.
|
CN106413750B
(zh)
|
2014-05-16 |
2022-04-29 |
免疫医疗有限责任公司 |
具有增强的治疗和诊断特性的带有改变的新生儿Fc受体结合的分子
|
EP3148580B1
(de)
|
2014-05-29 |
2021-01-20 |
MacroGenics, Inc. |
Trispezifische bindungsmoleküle mit spezifischer bindung an mehrere krebsantigene und verfahren zur verwendung davon
|
TWI693232B
(zh)
|
2014-06-26 |
2020-05-11 |
美商宏觀基因股份有限公司 |
與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法
|
EP3169708B1
(de)
|
2014-07-16 |
2019-03-20 |
Dana-Farber Cancer Institute Inc. et Al. |
Her3-inhibition bei serösem low-grade-ovarialkarzinom
|
WO2016020791A1
(en)
|
2014-08-05 |
2016-02-11 |
Novartis Ag |
Ckit antibody drug conjugates
|
WO2016024195A1
(en)
|
2014-08-12 |
2016-02-18 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates
|
AP2017009823A0
(en)
|
2014-09-26 |
2017-03-31 |
Macrogenics Inc |
Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
|
EA201791050A1
(ru)
|
2014-11-14 |
2017-09-29 |
Новартис Аг |
Конъюгаты антител и лекарственных средств
|
ES2926062T3
(es)
|
2014-12-09 |
2022-10-21 |
Sweetwater Energy Inc |
Pretratamiento rápido
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
US10766959B2
(en)
|
2014-12-11 |
2020-09-08 |
Pierre Fabre Medicament |
Anti-C10ORF54 antibodies and uses thereof
|
CN104479157B
(zh)
*
|
2015-01-06 |
2017-07-11 |
山东理工大学 |
一种聚己内酯与聚乙二醇改进聚肽膜亲水性与柔顺性的方法
|
US20160244520A1
(en)
|
2015-01-24 |
2016-08-25 |
Abbvie Inc. |
Compositions and methods for treating psoriatic arthritis
|
US10501552B2
(en)
|
2015-01-26 |
2019-12-10 |
Macrogenics, Inc. |
Multivalent molecules comprising DR5-binding domains
|
CN114504652A
(zh)
|
2015-03-03 |
2022-05-17 |
科马布有限公司 |
抗体、用途和方法
|
CA2987051A1
(en)
|
2015-05-29 |
2016-12-08 |
Abbvie Inc. |
Anti-cd40 antibodies and uses thereof
|
TWI773646B
(zh)
|
2015-06-08 |
2022-08-11 |
美商宏觀基因股份有限公司 |
結合lag-3的分子和其使用方法
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
US20190194315A1
(en)
|
2015-06-17 |
2019-06-27 |
Novartis Ag |
Antibody drug conjugates
|
CA3025896A1
(en)
|
2015-07-23 |
2017-01-26 |
The Regents Of The University Of California |
Antibodies to coagulation factor xia and uses thereof
|
PT3328419T
(pt)
|
2015-07-30 |
2021-11-26 |
Macrogenics Inc |
Moléculas de ligação pd-1 e métodos de utilização
|
US9862760B2
(en)
|
2015-09-16 |
2018-01-09 |
Novartis Ag |
Polyomavirus neutralizing antibodies
|
EA201890790A1
(ru)
|
2015-09-29 |
2018-10-31 |
Селджин Корпорейшн |
Связывающие pd-1 белки и способы их применения
|
EP3365369A1
(de)
|
2015-10-23 |
2018-08-29 |
Pfizer Inc |
Anti-il-2-antikörper sowie zusammensetzungen und verwendungen davon
|
EP3370694A1
(de)
|
2015-11-06 |
2018-09-12 |
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. |
Zusammensetzung mit einem biokompatiblen und biologisch abbaubaren polymer, nanoträger und arzneimittel sowie verfahren zur herstellung und verwendung davon
|
PT3377041T
(pt)
|
2015-11-16 |
2023-12-15 |
Maria Pereira Da Cruz Alves Garcia |
Método para morcelação e/ou direcionamento de princípios farmaceuticamente ativos ao tecido sinovial
|
EP3383908A1
(de)
|
2015-12-02 |
2018-10-10 |
Stsciences, Inc. |
Spezifische antikörper gegen glykosylierten btla (b- und t-lymphozyt-attenuator)
|
EP3909983A1
(de)
|
2015-12-02 |
2021-11-17 |
STCube & Co. Inc. |
Antikörper und moleküle, die immunspezifisch an btn1a1 binden, und therapeutische verwendungen davon
|
SG11201804839WA
(en)
|
2015-12-14 |
2018-07-30 |
Macrogenics Inc |
Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
|
US20210198368A1
(en)
|
2016-01-21 |
2021-07-01 |
Novartis Ag |
Multispecific molecules targeting cll-1
|
JP2019524651A
(ja)
|
2016-06-08 |
2019-09-05 |
アッヴィ・インコーポレイテッド |
抗cd98抗体及び抗体薬物コンジュゲート
|
US20200002421A1
(en)
|
2016-06-08 |
2020-01-02 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
EP3835322A3
(de)
|
2016-06-08 |
2021-10-06 |
AbbVie Inc. |
Anti-b7-h3-antikörper und antikörperarzneimittelkonjugate
|
US10766958B2
(en)
|
2016-09-19 |
2020-09-08 |
Celgene Corporation |
Methods of treating vitiligo using PD-1 binding antibodies
|
WO2018053405A1
(en)
|
2016-09-19 |
2018-03-22 |
Celgene Corporation |
Methods of treating immune disorders using pd-1 binding proteins
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
AU2017360346B2
(en)
|
2016-11-21 |
2023-11-23 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
US10899842B2
(en)
|
2016-11-23 |
2021-01-26 |
Immunoah Therapeutics, Inc. |
4-1BB binding proteins and uses thereof
|
JOP20190187A1
(ar)
|
2017-02-03 |
2019-08-01 |
Novartis Ag |
مترافقات عقار جسم مضاد لـ ccr7
|
EP3583223A4
(de)
|
2017-02-16 |
2020-12-23 |
Sweetwater Energy, Inc. |
Hochdruckzonenbildung zur vorbehandlung
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
JP7369038B2
(ja)
|
2017-05-31 |
2023-10-25 |
ストキューブ アンド シーオー., インコーポレイテッド |
Btn1a1に免疫特異的に結合する抗体及び分子並びにその治療的使用
|
JP2020522512A
(ja)
|
2017-05-31 |
2020-07-30 |
ストキューブ アンド シーオー., インコーポレイテッド |
Btn1a1に免疫特異的に結合する抗体及び分子を用いて癌を治療する方法
|
JP2020522562A
(ja)
|
2017-06-06 |
2020-07-30 |
ストキューブ アンド シーオー., インコーポレイテッド |
Btn1a1又はbtn1a1リガンドに結合する抗体及び分子を用いて癌を治療する方法
|
WO2019108639A1
(en)
|
2017-12-01 |
2019-06-06 |
Pfizer Inc. |
Anti-cxcr5 antibodies and compositions and uses thereof
|
CA3083363A1
(en)
|
2017-12-01 |
2019-06-06 |
Novartis Ag |
Polyomavirus neutralizing antibodies
|
AU2019234213A1
(en)
|
2018-03-12 |
2020-09-03 |
Zoetis Services Llc |
Anti-NGF antibodies and methods thereof
|
EP3774863A1
(de)
|
2018-03-29 |
2021-02-17 |
Pfizer Inc |
Lfa3-varianten sowie zusammensetzungen und verwendungen davon
|
US10633458B2
(en)
|
2018-04-10 |
2020-04-28 |
Y-Biologics Inc. |
Cell engaging binding molecules
|
WO2019229699A1
(en)
|
2018-05-31 |
2019-12-05 |
Novartis Ag |
Hepatitis b antibodies
|
CA3098420A1
(en)
|
2018-06-01 |
2019-12-05 |
Novartis Ag |
Binding molecules against bcma and uses thereof
|
AU2019306165A1
(en)
|
2018-07-20 |
2021-02-25 |
Pierre Fabre Medicament |
Receptor for vista
|
PE20211605A1
(es)
|
2018-09-07 |
2021-08-23 |
Pfizer |
ANTICUERPOS ANTI-avß8 Y COMPOSICIONES Y USOS DE LOS MISMOS
|
WO2020053742A2
(en)
|
2018-09-10 |
2020-03-19 |
Novartis Ag |
Anti-hla-hbv peptide antibodies
|
TW202039554A
(zh)
|
2018-12-19 |
2020-11-01 |
瑞士商諾華公司 |
抗TNF-α抗體
|
JP2022515760A
(ja)
|
2018-12-21 |
2022-02-22 |
ノバルティス アーゲー |
Pmel17に対する抗体及びその結合体
|
AU2020234394B2
(en)
|
2019-03-08 |
2024-02-15 |
AbTis Co., Ltd. |
Site-specific antibody conjugation and antibody-drug conjugate as specific example thereof
|
TW202102526A
(zh)
|
2019-04-04 |
2021-01-16 |
美商銳進科斯生物股份有限公司 |
重組腺相關病毒及其用途
|
EP4004214A1
(de)
|
2019-07-26 |
2022-06-01 |
RegenxBio Inc. |
Gentechnisch hergestelltes nukleinsäureregulationselement und verwendungsverfahren dafür
|
CN114729045A
(zh)
|
2019-09-26 |
2022-07-08 |
斯特库比公司 |
对糖基化的ctla-4特异性的抗体及其使用方法
|
CN110615829B
(zh)
*
|
2019-09-29 |
2022-07-19 |
深圳市三浦天然化妆品有限公司 |
一种自组装抗菌肽水凝胶
|
EP4041768A1
(de)
|
2019-10-09 |
2022-08-17 |
StCube & Co. |
Spezifische antikörper gegen glykosiertes lag3 und verfahren zur verwendung davon
|
WO2021133733A1
(en)
|
2019-12-22 |
2021-07-01 |
Sweetwater Energy, Inc. |
Methods of making specialized lignin and lignin products from biomass
|
US20230181756A1
(en)
|
2020-04-30 |
2023-06-15 |
Novartis Ag |
Ccr7 antibody drug conjugates for treating cancer
|
JP2023523760A
(ja)
|
2020-05-01 |
2023-06-07 |
ノバルティス アーゲー |
免疫グロブリン変異体
|
US20230242647A1
(en)
|
2020-05-01 |
2023-08-03 |
Novartis Ag |
Engineered immunoglobulins
|
US20230285576A1
(en)
|
2020-08-05 |
2023-09-14 |
Ellipses Pharma Ltd |
Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
EP4225777A2
(de)
|
2020-10-07 |
2023-08-16 |
RegenxBio Inc. |
Adeno-assoziierte viren zur okularen verabreichung einer gentherapie
|
EP4240494A1
(de)
|
2020-11-06 |
2023-09-13 |
Novartis AG |
Anti-cd19-mittel und auf b-zellen abzielende kombinationstherapie zur behandlung von b-zell-malignomen
|
KR20230104651A
(ko)
|
2020-11-06 |
2023-07-10 |
노파르티스 아게 |
Cd19 결합 분자 및 이의 용도
|
WO2022097065A2
(en)
|
2020-11-06 |
2022-05-12 |
Novartis Ag |
ANTIBODY Fc VARIANTS
|
JP2024502832A
(ja)
|
2020-12-31 |
2024-01-23 |
アラマー バイオサイエンシーズ, インコーポレイテッド |
高親和性及び/または特異性を有する結合剤分子ならびにその製造及び使用方法
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
GB202103785D0
(en)
*
|
2021-03-18 |
2021-05-05 |
UCB Biopharma SRL |
Formulations
|
WO2022221720A1
(en)
|
2021-04-16 |
2022-10-20 |
Novartis Ag |
Antibody drug conjugates and methods for making thereof
|
CN113354800A
(zh)
*
|
2021-06-22 |
2021-09-07 |
山东谷雨春生物科技有限公司 |
一种peg嵌段聚乙丙交酯及其应用
|
WO2023060272A2
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
WO2023060269A1
(en)
|
2021-10-07 |
2023-04-13 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
WO2023073599A1
(en)
|
2021-10-28 |
2023-05-04 |
Novartis Ag |
Engineered fc variants
|
WO2023077092A1
(en)
|
2021-10-28 |
2023-05-04 |
Regenxbio Inc. |
Engineered nucleic acid regulatory elements and methods and uses thereof
|
AR128222A1
(es)
|
2022-01-07 |
2024-04-10 |
Johnson & Johnson Entpr Innovation Inc |
MATERIALES Y MÉTODOS DE PROTEÍNAS DE UNIÓN A IL-1b
|
WO2023152633A1
(en)
|
2022-02-09 |
2023-08-17 |
Janssen Biotech, Inc. |
Methods and compositions comprising v beta 17 bispecific t cell engagers and bioengineered virus specific lymphocytes
|
TW202346590A
(zh)
|
2022-03-13 |
2023-12-01 |
美商銳進科斯生物股份有限公司 |
經修飾之肌肉特異性啟動子
|
WO2023201277A1
(en)
|
2022-04-14 |
2023-10-19 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
WO2023201308A1
(en)
|
2022-04-14 |
2023-10-19 |
Regenxbio Inc. |
Gene therapy for treating an ocular disease
|
WO2023205610A2
(en)
|
2022-04-18 |
2023-10-26 |
Regenxbio Inc. |
Hybrid aav capsids
|
WO2023209568A1
(en)
|
2022-04-26 |
2023-11-02 |
Novartis Ag |
Multispecific antibodies targeting il-13 and il-18
|
WO2024013727A1
(en)
|
2022-07-15 |
2024-01-18 |
Janssen Biotech, Inc. |
Material and methods for improved bioengineered pairing of antigen-binding variable regions
|
WO2024018426A1
(en)
|
2022-07-22 |
2024-01-25 |
Janssen Biotech, Inc. |
Enhanced transfer of genetic instructions to effector immune cells
|
WO2024028732A1
(en)
|
2022-08-05 |
2024-02-08 |
Janssen Biotech, Inc. |
Cd98 binding constructs for treating brain tumors
|
WO2024028731A1
(en)
|
2022-08-05 |
2024-02-08 |
Janssen Biotech, Inc. |
Transferrin receptor binding proteins for treating brain tumors
|
WO2024044725A2
(en)
|
2022-08-24 |
2024-02-29 |
Regenxbio Inc. |
Recombinant adeno-associated viruses and uses thereof
|
WO2024081746A2
(en)
|
2022-10-11 |
2024-04-18 |
Regenxbio Inc. |
Engineered nucleic acid regulatory elements and methods and uses thereof
|